Standout Papers
- Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes (2007)
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors (1995)
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less (1997)
Immediate Impact
7 by Nobel laureates 2 from Science/Nature 105 standout
Citing Papers
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection
2022 Standout
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
2017 Standout
Works of Kathleen Squires being referenced
Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study
2016
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kathleen Squires | 5054 | 4334 | 1646 | 81 | 6.9k | |
| Jacques Reynes | 4938 | 3817 | 2219 | 204 | 7.8k | |
| Jan W. Mulder | 3456 | 2834 | 1140 | 158 | 6.2k | |
| Jeffrey Chodakewitz | 4121 | 3973 | 1290 | 24 | 6.1k | |
| Ronald Brookmeyer | 3179 | 3951 | 1375 | 43 | 7.3k | |
| Pedro Cahn | 7264 | 5148 | 2536 | 214 | 9.1k | |
| Lisa M. Demeter | 4635 | 4342 | 1320 | 83 | 6.0k | |
| Richard C. Reichman | 4073 | 3312 | 3121 | 116 | 7.3k | |
| Joseph B. Margolick | 4091 | 5360 | 2262 | 131 | 8.9k | |
| Cécile Tremblay | 2670 | 3122 | 1694 | 237 | 6.0k | |
| Gitte Kronborg | 2607 | 1633 | 2170 | 167 | 6.3k |
All Works
Loading papers...